Influenza
1,376
53
83
1,113
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
462 trials with published results (34%)
Research Maturity
1113 completed trials (81% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
3.1%
42 terminated out of 1376 trials
96.4%
+9.8% vs benchmark
36%
495 trials in Phase 3/4
42%
462 of 1113 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1113 completed trials
Clinical Trials (1376)
Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)
Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates
Randomized Controlled Trial to Evaluate the Efficacy of Surgical Masks in Preventing Acute Respiratory Infections
BPL-1357 Against H1N1 Influenza Virus Challenge
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Influenza Vaccination Strategy for Patients With Hematologic Malignancy
Immunogenicity of Influenza Vaccinations
pH1N1 Blinded Challenge Study
Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
The Effects of Endotracheal Suctioning on Pain and Serum Markers
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho
Smart Analysis and Decision-Making for Emerging Infectious Diseases
Patient-Centered Practical Vaccine Talk For Busy Clinicians